ANRO
#2497
Alto Neuroscience, Inc. Common Stock
27.6 5 USD
-0.01%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-1.36%
Monthly Change
+28.49%
6 month change
+63.32%
Year Change
+916.54%
Previous Close
28.0 3
Open
26.7 1
Low
26.2 2
High
27.6 5
Volume
170
Financials
- Market Capitalization 970.35 M
- Employee 68
- Founded 2019
- CEO -
- Website www.altoneuroscience.com
- Headquarter Delaware, United States
- FIGI BBG00WYFS6R5
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-8.13
Price to sales ratio
-613.58
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2483 |  AVTX Avalo Therapeutics, Inc. - Common Stock | 18.69 USD | -1.16% | -4.10% | +24.52% | +280.65% | 982.45 M USD | ||
| 2486 |  KURA Kura Oncology, Inc. - Common Stock | 11.36 USD | +4.12% | -4.05% | +23.75% | +77.78% | 1.01 B USD | ||
| 2500 |  PHAR Pharming Group N.V. - ADS, each representing 10 | 13.30 USD | -3.27% | -7.12% | +1.14% | +27.64% | 933.23 M USD | ||
| 2501 |  SLDB Solid Biosciences Inc. - Common Stock | 9.86 USD | +1.44% | -9.87% | +35.63% | +72.98% | 970.71 M USD |
Frequently asked questions about Alto Neuroscience, Inc. Common Stock
What is the Alto Neuroscience, Inc. Common Stock stock price today?
The current price of Alto Neuroscience, Inc. Common Stock (ANRO) is 27.65. Over the past 24 hours, the stock has changed by -1.36%. Follow the ANRO chart for real-time price dynamics.
What is the stock ticker of Alto Neuroscience, Inc. Common Stock?
Alto Neuroscience, Inc. Common Stock trades under the ticker ANRO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Alto Neuroscience, Inc. Common Stock stock going up?
ANRO has changed by +7.42% over the last week, +28.49% over the last month, and +916.54% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Alto Neuroscience, Inc. Common Stock net income for the last quarter?
Alto Neuroscience, Inc. Common Stock reported net income of -26.24 M for the last quarter. The previous quarter showed -16.18 M, which means net income changed by -62.14%.
How many employees does Alto Neuroscience, Inc. Common Stock have?
As of the latest available data, Alto Neuroscience, Inc. Common Stock has 68 employees. Workforce size can provide additional context about the company's scale and operations.
What is Alto Neuroscience, Inc. Common Stock EBITDA?
Alto Neuroscience, Inc. Common Stock EBITDA is -26.96 M, and its EBITDA margin is 299.59 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Alto Neuroscience, Inc. Common Stock stock?
You can buy Alto Neuroscience, Inc. Common Stock (ANRO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Alto Neuroscience, Inc. Common Stock stock?
Investing in Alto Neuroscience, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ANRO chart and related analysis on metatrader.com as part of your research.